Medication Errors in Pediatric Transitions: A Comprehensive Review for Clinicians

Abstract

Medication errors during pediatric transitions of care remain a significant threat to patient safety, with consequences ranging from minor adverse drug events to serious, potentially fatal outcomes. This review synthesizes current literature, epidemiological trends, underlying mechanisms, risk factors, and clinical features associated with pediatric medication errors, alongside diagnostic approaches, management strategies, recent advances, and guideline recommendations. Practical implications for clinicians are discussed, emphasizing the necessity of robust, evidence-based interventions to mitigate harm and improve outcomes during vulnerable transitional periods in pediatric care.

Introduction

Transitions of care in pediatric patients—such as admission, transfer between units, and discharge—are recognized as high-risk periods for medication errors. The complexity inherent to pediatric pharmacotherapy, including weight-based dosing, age-specific pharmacokinetics, and communication barriers, exacerbates vulnerability to error. This article provides a detailed, evidence-based review for clinicians on the epidemiology, risk factors, pathophysiology, and clinical management of medication errors in this context, drawing on current guidelines and emerging scientific insights.

Epidemiology / Disease Burden

Medication errors are among the most common adverse events in pediatric practice. Studies estimate error rates of 5–27% during pediatric transitions of care, with higher rates in intensive care and oncology settings. According to a multicenter cohort study published in JAMA Pediatrics (2022), nearly 15% of pediatric inpatients experience at least one medication error during transitions, with about 3% resulting in harm. The burden is particularly high among neonates and infants due to developmental pharmacology and communication challenges, as highlighted in recent systematic reviews.

Pathophysiology

Pathophysiologically, medication errors in pediatric transitions often arise from multifactorial causes: inaccurate weight documentation, miscommunication between providers, interruptions during handoffs, and lack of standardized reconciliation protocols. Pediatric patients are uniquely susceptible due to dynamic changes in organ maturation, altered drug metabolism, and narrow therapeutic indices. Errors in calculation or transcribing dosages—such as misplaced decimal points—may lead to significant overdosing or underdosing, with profound clinical consequences.

Risk Factors

Several risk factors contribute to medication errors during pediatric transitions. These include: complex medication regimens, frequent changes in care providers, inadequate medication histories, lack of standardized handoff processes, limited caregiver health literacy, and electronic health record (EHR) interoperability issues. Additionally, specific patient populations—such as those with chronic illness, polypharmacy, or language barriers—are at heightened risk. Environmental factors, including high workload, staff fatigue, and time pressures, further exacerbate risk during transitions.

Clinical Features

Medication errors may manifest clinically as unexpected changes in vital signs, altered mental status, allergic reactions, or unexplained clinical deterioration. Non-specific symptoms—such as lethargy, irritability, or feeding difficulties—may be early indicators, especially in non-verbal children. In many cases, errors are detected only through vigilant monitoring and high clinical suspicion, underscoring the importance of thorough assessment during and after transitions of care.

Diagnosis

Diagnosis of medication errors relies on careful review of medication orders, administration records, and reconciliation processes. Tools such as the Medication Error Reporting and Prevention (MERP) Index facilitate categorization and analysis. The use of trigger tools, such as electronic alerts for abnormal lab values or out-of-range dosages, can aid in early detection. Root cause analysis following identification of errors is crucial to prevent recurrence, with a multidisciplinary approach recommended for comprehensive evaluation.

Treatment & Management

Immediate management of medication errors involves prompt recognition, assessment of clinical impact, and initiation of appropriate interventions—such as antidote administration, supportive care, or cessation of the offending agent. Communication with the patient\'s family is vital, both for transparency and to facilitate monitoring for delayed adverse effects. Long-term management focuses on system-based solutions: implementation of structured medication reconciliation, use of clinical decision support systems, and ongoing education for healthcare providers and caregivers.

Recent Advances / Emerging Therapies

Recent advances in health information technology have facilitated safer transitions. Integration of computerized physician order entry (CPOE) with pediatric-specific dosing calculators, barcode medication administration, and real-time clinical decision support have demonstrated reductions in error rates. Mobile health tools enabling family engagement, and artificial intelligence-based predictive analytics, are emerging as promising strategies. Simulation-based training for healthcare teams has also shown efficacy in improving handoff communication and reducing errors.

Guideline Recommendations

Professional societies—including the American Academy of Pediatrics and the Institute for Safe Medication Practices—recommend standardized handoff protocols, mandatory medication reconciliation at all transition points, and use of weight-based dosing charts. Guidelines emphasize the importance of multidisciplinary teamwork, standardized communication tools (such as SBAR), and regular audit-feedback cycles. Ongoing provider education and family-centered care are core components of error prevention strategies.

Conclusion

Medication errors during pediatric transitions remain a critical patient safety concern, driven by complex interplay of physiological, systemic, and human factors. Evidence-based strategies—including robust reconciliation processes, technological innovations, and adherence to guideline-driven protocols—offer effective means to reduce harm. Continued investment in education, research, and system redesign is essential for improving outcomes and ensuring safe, high-quality care for pediatric patients throughout their healthcare journey.